Roflumilast Cream Remains Effective, Tolerable for Plaque Psoriasis Over 24-Week Open-Label Extension
New phase 3 extension data show the topical PDE-4 inhibitor provided skin clearance to a significant rate of patients with psoriasis.
Study: Sickle Cell Disease Pain Management Education Needs to be Streamlined
New research from the UK suggests educational tools for caregivers are in use and beneficial, but none are universally applied.
Trazodone Frequently Prescribed in Insomnia Care, Despite Guidelines
National prescribing cohort data suggest clinicians buck against the recommended use of the antidepressant.
GSK to Submit Older Adult RSV Vaccine Candidate to FDA in 2022
The decision comes after the company announced positive phase 3 data for the combination vaccine candidate in adults aged 60 years and older.
Sleep Apnea Treatment Initiation Linked to Reduced Long-Term Health Costs
A team of investigators observe notably improved health care cost savings among patients who initiated care more than a year prior to those who haven't at all.
Metabolomic Risk Score Could Inform Obstructive Sleep Apnea Risk
Investigators show a novel risk score helped define more than a dozen metabolites associated with the chronic sleep condition.
Uncovering Clinical Meaning of Sleep in Early Cognitive Development
Mark Blumberg, MD, discusses his laboratory's particular interest in early REM sleep movement, and its potential impact on neurological disorders.
Excessive Daytime Sleepiness Subtype Linked to Doubled Risk of Incident Myocardial Infarction
Investigators contribute more detailed understanding of the association between sleeping disorder and cardiovascular event risks.
Sleep Apnea, Daytime Sleepiness Associated With Increased Atherosclerosis Risk and Progression
Late-breaking data from SLEEP 2022 show there may be biological plausibility for cardiovascular risks in excessively sleepy individuals.
Post-Hospitalized COVID-19 Patients Fare Worse in Sleep Quality, Daytime Fatigue Scores
Even after controlling for differences in age and BMI, investigators observe a greater burden of sleep health on those who had severe COVID-19 versus the general population.
PTSD Among Men, People of Color Linked to REM Sleep Behavior Disorder Risk
Investigators observe an increased risk of dream enactment among specific subgroups of veterans with trauma.
Pediatric Obstructive Sleep Apnea Burden, CPAP Use Not Affected by COVID-19
Data from SLEEP 2022 suggests children with OSA may have faced worse psychosocial burden during the pandemic.
Children With Asthma Face Significantly Greater Risk of Sleep-Disordered Breathing
A new study from SLEEP 2022 showed asthmatic children have a 10 times greater risk of the condition, and are twice as likely to have a history of snoring.
Lemborexant Improves Sleep Onset Latency, Wake After Sleep Onset in Insomnia Patients
New SUNRISE 2 data show a subjective, dose-dependent, and disease severity-dependent benefit with the insomnia therapy.
Lower Sodium Oxybate May Provide Weight Loss for Adults with Idiopathic Hypersomnia
The FDA-approved sleep agent was associated with ≥5% weight loss in more than one-quarter of patients in a phase 3 trial.
NT-proBNP Serves as Cardiovascular Event, Death Biomarker in Post-ACS Patients with Diabetes
Prof. Hertzel Gerstein discusses new ELIXA biomarker findings from ADA 2022.
Roy Taylor, MD: Using Personal Fat Thresholds to Reach Type 2 Diabetes Remission
The diabetologist and professor discusses new findings from the ReTUNE trial, which disparage the utility of BMI in defining diabetes risk and remission opportunity.
Semaglutide Significantly Reduces Long-Term Diabetes Risk Among Obesity Patients
New post hoc data from the STEP 1 and 4 trials show an approximate 60% risk reduction of type 2 diabetes over 10 years versus placebo.
Educating Psychiatry Trainees on Social Determinants of Health
A Montefiore residency director explains the impact of engaging with communities to improve mental health care capability.
Yoga vs Antidepressants: Defining Workplace Burnout Over Mental Health Issues
Montefiore's Carol A. Bernstein, MD, discusses the role of psychiatry specialists in discerning their colleagues' need for mental health care or resolutions to burnout.
Sleep Pharmacotherapy, Melatonin, and the Link to Substance Use Disorders
Gina Poe, PhD, discusses the potential role of beta blockers in treating psychiatric illness-related sleep, as well as the specific benefit of melatonin.
Mental Health Disparities Among the Hispanic Population
NIDA research director Carlos Blanco-Jerez, MD, PhD, reviews how stigma, language barriers and digital health create disparate outcomes in mentally-ill Hispanic patients.
The New Era of Borderline Personality Disorder Care
Lois Choi-Kain, MD, MEd, discusses her field's interest in improving the modern diagnosis and evidenced-based treatment of personality disorders.
Gina Poe, PhD: How Psychiatric Diseases Impact Sleep Health
The UCLA-based investigator discusses the unique impact of PTSD on patients' sleep stages, and how they can limit their insomnia.
Nora D. Volkow, MD: The Pain Crisis, and Optimizing Addiction Care Delivery
The director of NIDA discusses the interplay of substance use disorder and pain in patients, as well as means to assure patients are receiving evidenced-based treatment.
Identifying and Treating Adolescent Borderline Personality Disorder
Lois Choi-Kain, MD, MEd, discusses the unique presentations of disease and burdens of care that impact younger patients with BPD.
The Psychiatry Blueprint to Retaining Diverse Trainees, Treating Disparity
The modern psychiatrist may play many roles, including as a mentor and a facilitator to social-based support.
Nora D. Volkow, MD: Advancing Clinical Research for Treating Use Disorders
The NIDA director reviews neuromodulation's potential role in treating patients with multiple use disorders, and the importance of patient feedback in shaping clinical research.
Challenges in Psychiatry Patient Disparities and Caregiver Representation
Rachel Talley, MD, discusses the industry-level changes needed to trainee recruitment and retention to create a psychiatry field more representative of its patient population.
The Ketamine & Esketamine Care Teams, and Necessary Monitoring
With administration strategies for the psychiatric anesthetic drug well established, clinicians have interest in accumulating long-term data and other potential indications.
2 Clarke Drive Cranbury, NJ 08512